What should I expect during a PET scan for Testicular Cancer

What to Expect During a PET Scan for Testicular Cancer

I'm glad you're preparing for this test—understanding what happens can help reduce anxiety and make the experience smoother.

Overview: What a PET Scan Does

A PET (positron emission tomography) scan is an imaging test that helps your doctor see if cancer cells are present in your body and how active they are. According to NCCN Guidelines for testicular cancer, a FDG-PET/CT scan (which combines PET with CT imaging) may be used to evaluate residual masses (remaining tissue after treatment) to determine if they contain active cancer cells or just scar tissue.

The Basic Process

Before Your Scan:

• You'll receive an injection of a radioactive tracer (a special substance) into a vein, usually in your arm
• This tracer is made from a simple sugar called glucose (FDG - fluorodeoxyglucose)
• You cannot eat or drink for at least 4 hours before the scan to ensure accurate results
• The tracer needs about 1 hour to circulate through your body before imaging begins

During Your Scan:

• You'll lie on a table that slides into the PET/CT scanner
• The machine takes pictures from different angles
• The scan typically takes 30-60 minutes
• You need to remain as still as possible during imaging
• The machine is not painful—you won't feel the radiation
• You may hear humming or clicking sounds from the equipment

After Your Scan:

• The radioactive tracer leaves your body naturally through urine over the next several hours
• You can return to normal activities immediately
• Drink extra fluids to help flush the tracer from your system

Important Context for Testicular Cancer

According to NCCN Guidelines, PET scans have specific uses and limitations in testicular cancer:

When PET is Recommended:

• For residual masses larger than 3 cm with normal tumor markers (AFP and beta-hCG)
• To help determine if remaining tissue contains viable (living) cancer cells or just scar tissue
• The scan should be performed at least 6 weeks after completing chemotherapy to reduce false-positive results from inflammation

Important Limitations to Understand:

• Testicular cancers typically grow slowly and may not show up brightly on PET scans
• Small tumors (less than 3 cm) are not reliably detected by PET, so PET is not recommended for small residual masses
• The abdomen and retroperitoneal space (area behind the abdominal organs) can show false-positive results due to normal inflammation
• A negative PET scan is very reassuring, but a positive result may need further evaluation with repeat imaging or biopsy

Questions to Ask Your Healthcare Team

Before your PET scan, consider asking:

1. Why specifically am I having this PET scan? (What are you looking for, and what will it help determine about my treatment?)
2. What does my residual mass size mean? (Is it larger or smaller than 3 cm, and how does that affect interpretation?)
3. How long after my last chemotherapy was this scheduled? (Timing matters for accuracy)
4. What happens if the results are positive or negative? (What are the next steps either way?)
5. Will I need any other imaging tests? (CT, MRI, or follow-up PET scans?)

What the Results Mean (Educational Context)

• Negative or indeterminate results: Generally reassuring; surveillance (careful monitoring) is typically recommended
• Positive results: May indicate viable tumor cells; your doctor may recommend repeat imaging in 6-8 weeks, a biopsy, or surgical removal of the mass
• Your oncologist will interpret results in context of your complete clinical picture, including your tumor markers and other imaging

Practical Tips

• Wear comfortable, loose clothing (no metal zippers or buttons)
• Arrive 15 minutes early
• Bring a list of any medications you're taking
• Let your care team know if you have claustrophobia or anxiety about enclosed spaces
• Ask if someone can accompany you for support

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Testicular Cancer (Version 1.2026); NCCN Guidelines for Patients on imaging procedures